Compare ImmunityBio Inc. Common Stock (IBRX) vs Rio Tinto (ADR) (RIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Rio Tinto (ADR) — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.51B), while Rio Tinto (ADR) trades at $94.2 (market cap $151.50B). The key difference: Rio Tinto (ADR) is far larger — about 14.4× ImmunityBio Inc. Common Stock's market cap, and Rio Tinto (ADR) pays a 4.99% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Rio Tinto (ADR) for 10 Days on average.
| IBRX | RIO | |
|---|---|---|
Market Cap | $10.51B | $151.50B |
Volume | 10,445,785 | 2,164,712 |
Sector | Health | Basic Materials |
52-Week High | $11.55 | $112.04 |
52-Week Low | $1.98 | $65.44 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $10.97B | $164.84B |
Dividend Yield | — | 4.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Rio Tinto (ADR)
Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.
Read more on RIO →
